翁沥通胶囊联合西药治疗良性前列腺增生症48例

Wenglitong Capsule and Western Medicine in Treatment of Benign Prostatic Hyperplasia

目的:观察翁沥通胶囊联合西药治疗良性前列腺增生症(BPH)的疗效。方法:良性前列腺增生症患者随机分为两组,对照组52例采用单纯西药治疗,治疗组48例在对照组治疗基础上加口服翁沥通胶囊,3粒/次,2次/d,均连续12周。观察两组治疗前后(IPSS)评分、生活质量(QOL)评分、最大尿流率(MFR)、前列腺体积(V)、前列腺液WBC计数,比较两组疗效。结果:治疗组IPSS评分、QOL评分、最大尿流率、前列腺液WBC计数方面优于对照组,治疗组总有效率93.75%,对照组总有效率86.53%,在前列腺体积的改善上无明显差异。结论:翁沥通胶囊联合西药治疗良性前列腺增生症临床疗效和改善生活质量要明显优于单纯西药治疗。

Objective： To evaluate the clinical therapeutic effect of the combination of Wenglitong capsule and western medicine in the treatment of benign prostatic hyperplasia. Method： Fifty two cases of control group treated by western medicine, 48 cases of treatment group treated by the combination of Wenglitong capsule and western medicine, international prostate symptom sore （ IPSS）, quality of life （ QOL）, maximum flow rate （ MFR）, volume （ V）, white blood cell （WBC） were compared between two groups in the pre-theatment and had been theated 12 weeks. Rusult： IPSS, QOL, MFR, WBC of two groups presented siginificant statistical difference in comparison. Treatment group superior to control group. The total effective was 94% in treatment group, the total effective was 85% in control group. There were no difference on V. Conclusion： The combination of Wenglitong capsule and western medicine in the treatment of benign prostatic hyperplasia can improve more obviously impacts and quaulity of life than by western medicine only.